加科思-B早盘涨超7% 首创新药戈来雷塞有望上半年获批上市

金融界
24 Mar

加科思早盘股价上涨7.65%,现报3.66港元,成交额1335.60万港元。 3月19日,加科思-B公布2024年业绩,实现收入约1.56亿元,同比增长145.2%。毛利约1.56亿元,同比增长4765.6%。收入增长主要得益于与艾力斯达成的9亿元里程碑合作协议。 该公司于2024年在资产的临床发展方面取得巨大进展。在所有处于临床阶段候选药物中, glecirasib(JAB-21822)是公司的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10